Bacterial translocation from the gastrointestinal tracts of rats receiving thermal injury.

Infection and Immunity
K MaejimaR D Berg

Abstract

Rats receiving nonlethal thermal burns over 20 or 40% of their total body surface area were tested at various intervals for the translocation of indigenous bacteria from their gastrointestinal tracts to their mesenteric lymph nodes, peritoneal cavities, and bloodstreams. No indigenous bacteria were cultured from these organs of control rats or from rats receiving 20% burns. However, 44% of the rats receiving 40% burns exhibited viable Escherichia coli, Proteus mirabilis, Staphylococcus sp. and Clostridium sp. in their mesenteric lymph nodes 2 days after thermal injury. Bacterial translocation after burn stress also was tested in antibiotic-decontaminated rats monoassociated with E. coli. E. coli attained population levels in these animals of 10(8) to 10(9) per g cecum. E. coli translocated to 100% of the mesenteric lymph nodes of both the control and 40% burned rats. However, E. coli translocated at a greater incidence to the spleens, livers, and peritoneal cavities of the burned rats compared with translocation to these organs in control rats. The numbers of E. coli translocating to the mesenteric lymph nodes, spleens, and livers also were greater in the 40% burned rats than in control rats. By 14 days after thermal injury, th...Continue Reading

References

Sep 1, 1979·The Journal of Trauma·C C BakerD D Trunkey
Jul 1, 1977·Annals of Surgery·A B BjornsonH S Bjornson
Apr 1, 1972·The Journal of Trauma·E E Howerton, S N Kolmen
Mar 15, 1969·Lancet·G ArtursonJ Killander
Dec 1, 1972·The American Journal of Clinical Nutrition·A Aranki, R Freter
Dec 1, 1980·Annals of Surgery·A M MunsterP Keeling
Feb 1, 1980·Infection and Immunity·W E Owens, R D Berg
Mar 1, 1982·The Journal of Trauma·E A DeitchJ C McDonald
Aug 1, 1964·Annals of Surgery·H L WALKERG L RAULSTON

❮ Previous
Next ❯

Citations

Jan 1, 1992·Intensive Care Medicine·C E HarrisR R Macmillan
Aug 1, 1995·Digestive Diseases and Sciences·F G MoodyD M Muncy
Aug 1, 1995·The Journal of Trauma·H YamamotoA A Meyer
Mar 1, 1994·Digestive Diseases and Sciences·U SchoeffelE H Farthmann
Jun 1, 1996·Critical Care Medicine·C L WellsS L Erlandsen
Oct 1, 1996·The Journal of Trauma·H YamamotoA A Meyer
Aug 26, 2006·Cell and Tissue Banking·Ted Eastlund
Jun 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Laszlo M HoeselPeter A Ward
Jul 12, 2013·PloS One·Fangming XiuMarc G Jeschke
Dec 19, 2014·Biochemistry. Biokhimii︠a︡·D B ZorovP S Savina
Jul 28, 2020·Veterinary Medicine and Science·Jia CuiBaojiang Chen
Jan 1, 1991·JPEN. Journal of Parenteral and Enteral Nutrition·K KuroiwaS Inoue
Mar 1, 1989·Journal of Clinical Immunology·C D MillsD S Gann
Feb 19, 1998·The American Journal of Gastroenterology·H O Conn
Jun 1, 1995·Digestive Diseases and Sciences·F C MorencosF Pons Romero
Dec 10, 1999·Current Opinion in Clinical Nutrition and Metabolic Care·G A Nieuwenhuijzen, R J Goris
Sep 10, 2005·The Journal of Burn Care & Rehabilitation·Louis J Magnotti, Edwin A Deitch
Mar 1, 1996·Digestive Diseases and Sciences·F Casafont MorencosF Pons Romero
Aug 26, 1998·The British Journal of Surgery·B KavukluI Sayek
Apr 1, 1997·Journal of Clinical Pathology·H B CoutinhoD Wakelin
Nov 4, 2011·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Jae Jeong ParkYoung Soo Nam
Apr 17, 2001·The Journal of Burn Care & Rehabilitation·W T ChanceC Ogle
Mar 9, 2005·Respiration; International Review of Thoracic Diseases·S OzkurtC O Kara
Nov 17, 2004·Shock·Carol L WellsStanley L Erlandsen
Nov 29, 2007·Current Opinion in Gastroenterology·Mohamed OthmanHenry C Lin
Jan 25, 2008·Journal of Applied Microbiology·G T MacfarlaneS Macfarlane
Jul 29, 2010·Physiological Reviews·Inna SekirovB Brett Finlay
Oct 31, 1998·Antimicrobial Agents and Chemotherapy·T MatsumotoK Yamaguchi
Feb 26, 1998·Journal of Applied Physiology·J W HortonB Sanders

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.